NCT01785901已完成不适用
The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,502
- 试验地点
- 2
- 主要终点
- The rate of controlled and partly controlled asthma according to the definition of Global Initiative for Asthma
研究概览
简要总结
This is a multi-centre, cross-sectional study planned to be conducted in China. The study aims to observe about 1500 asthma patients who have already received budesonide/formoterol combination treatment by physicians' determination and whose medications are aligned with the package insert of budesonide/formoterol approved in China.
详细描述
The asthma control rate achieved by budesonide/formoterol in clinical practice in China.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of asthma at least 6 months;
- •Prescribed with budesonide/formoterol treatment at least 3 months before enrolled;
- •Has used the same maintenance dose of budesonide/formoterol for at least 4 weeks before enrolled.
排除标准
- •Participation in any clinical study within 3 months;
- •Have COPD history/suspicious COPD;
- •≥ 10 pack years of smoking history
- •Used any other asthma maintenance medication accompanied with budesonide/formoterol within 3 months before enrolled
- •With asthma exacerbation (defined as asthma symptom deterioration resulting oral/rectal/parenteral GCS medication or emergency room treatment or hospitalisation) within 4 weeks before enrolled
结局指标
主要结局
The rate of controlled and partly controlled asthma according to the definition of Global Initiative for Asthma
时间窗: one day
次要结局
- The rate of completely controlled and well controlled asthma according to Asthma Control Test's score(one day)
- The average frequency of reliever use in previous week(one day)
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
Clinical Study on Chinese Children's Asthma Action PlanAsthma in ChildrenNCT03435822Beijing Children's Hospital400
进行中（未招募）
不适用
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma PatientsAsthmaNCT06605885AstraZeneca202
已完成
1 期
A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild AsthmaWheezingReactive Airway DiseaseMild AsthmaNCT03421730Vectura Limited17
已完成
2 期
Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of ARSeasonal Allergic RhinitisNCT00938613Ligand Pharmaceuticals65
已完成
3 期
Budesonide for Induction of Remission in Incomplete Microscopic ColitisIncomplete Microscopic ColitisNCT02142634Dr. Falk Pharma GmbH44